First Trust Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

First Trust Advisors’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,365,319	Closed	-$4.85M	–	2602
2021 Q4	$4.85M	Buy	4,365,319 +1,841,135	+73%	+$2.84M	﹤0.01%	1385
2021 Q3	$4.67M	Buy	2,524,184 +468,367	+23%	+$1.05M	0.01%	1358
2021 Q2	$6.52M	Buy	2,055,817 +803,796	+64%	+$2.01M	0.01%	1180
2021 Q1	$4.07M	Buy	+1,252,021	New	+$4.53M	﹤0.01%	1366
2020 Q2	–	Sell	-618,481	Closed	-$218K	–	2475
2020 Q1	$218K	Buy	618,481 +64,425	+12%	+$67.3K	﹤0.01%	2175
2019 Q4	$814K	Buy	554,056 +451,240	+439%	+$1.57M	﹤0.01%	1962
2019 Q3	$828K	Buy	102,816 +48,435	+89%	+$659K	﹤0.01%	1942
2019 Q2	$961K	Buy	54,381 +20,885	+62%	+$457K	﹤0.01%	1869
2019 Q1	$1.04M	Sell	33,496 -46,152	-58%	-$1.55M	﹤0.01%	1846
2018 Q4	$2.34M	Buy	79,648 +70,974	+818%	+$3.23M	0.01%	1384
2018 Q3	$654K	Buy	+8,674	New	+$587K	﹤0.01%	2101

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Trust Advisors's ASXC Position: Q1 2022 in Review

First Trust Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q1 2022, closing a stake of 4,365,319 shares — an estimated $4.85M sold.

First Trust Advisors first reported a position in ASXC in Q3 2018 and held it in 11 quarters. The position peaked at $6.52M in Q2 2021. 115 funds tracked by Wall St. Rank hold ASXC as of Q1 2022.

First Trust Advisors reported no remaining Asensus Surgical, Inc. position as of Q1 2022 after selling out during the quarter.
First Trust Advisors sold 4,365,319 Asensus Surgical, Inc. shares in Q1 2022, an estimated $4.85M.
First Trust Advisors first reported a position in Asensus Surgical, Inc. in Q3 2018 and held it in 11 quarters.
First Trust Advisors's Asensus Surgical, Inc. position peaked at $6.52M in Q2 2021.
115 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2022.

Based on First Trust Advisors's 13F filing for Q1 2022, filed 13 May 2022.